Bli medlem
Bli medlem

Du är här


Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - Interim Report Q2 2020 - invitation to conference call and webcast

The Company will hold a conference call and an online presentation on the same day at 11.00 am CET. The call will be hosted by Emil Billbäck, CEO and Håkan Johansson, CFO who will present the results and answer questions. The presentation will be held in English.


The dial-in numbers for the conference call are:

UK: +44 3333 000 804, PIN: 85994259#

SE: +46 8 505 583 68

US: +1 8338 230 589


The presentation will be webcasted and can be accessed from the following web address:


For more information contact:

Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87


BONESUPPORT™ (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT ( The Company is conducting several clinical studies to further demonstrate the clinical and health economic benefits that its products deliver and a Premarket approval filing with the FDA (USA) for CERAMENT G ( is planned in 2021. The Company is based in Lund, Sweden, and the net sales amounted to SEK 155 million in 2019. Please visit for more information.

BONESUPPORT and CERAMENT are registered trademarks ( of BONESUPPORT AB.

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.